Strategies for Combatting Multidrug-Resistant and Extensively Drug-Resistant Bacteria, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "The Global Need for Effective Antibiotics".
Deadline for manuscript submissions: 15 October 2024 | Viewed by 477
Special Issue Editors
Interests: cross-resistance; antibiotic resistance; efflux pumps; Salmonella
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first volume of the Special Issue “Strategies for Combatting Multidrug-Resistant and Extensively Drug-Resistant Bacteria: Current Challenges and Future Prospects ” was published in October 2023. It is a successful issue with nine published papers, encouraging us to open a second volume on the same topic.
As a continuation of the first Special Issue, this second volume will also focus on new strategies, including those that are not only related to novel antimicrobial drugs, but also those related to uncommon drug strategies. The topics of interest include, but are not limited to, the following:
- MDR bacteria;
- EDR bacteria;
- Novel antimicrobial drugs;
- Novel therapeutical approaches against MDR;
- Novel therapeutical approaches against EDR;
- Guidelines;
- Personalized microbiota;
- Bacteriophages;
- Autovaccine therapy;
- Antimicrobial stewardship.
Dr. Bożena Futoma-Kołoch
Dr. Anna Kędziora
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- MDR bacteria
- EDR bacteria
- novel antimicrobial drugs
- novel therapeutical approaches against MDR
- novel therapeutical approaches against EDR
- guidelines
- personalized microbiota
- bacteriophages
- autovaccine therapy
- antimicrobial stewardship
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
